Glucocorticoid and mineralocorticoid receptor agonists/antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
G03AC Progestogens
G03AC10 Drospirenone
D03917 Drospirenone (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Contraceptives
Oral Progestins
Drospirenone
D03917 Drospirenone (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
25 Urogenital and anal organ agents
254 Contraceptives
2549 Others
D03917 Drospirenone (JAN/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG03231 Antihypertensive
DG01676 Aldosterone antagonist
D03917 Drospirenone
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D03917 Drospirenone
Drug classes [BR:br08332]
Cardiovascular agent
DG01676 Aldosterone antagonist
D03917 Drospirenone
DG03231 Antihypertensive
D03917 Drospirenone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C2 (MR)
D03917 Drospirenone (JAN/USP/INN) <JP/US>
NR3C3 (PGR)
D03917 Drospirenone (JAN/USP/INN) <JP/US>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03917
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03917